Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight

Abstract Background Highly-effective CFTR-modulator therapy with elexa-/teza-/ivacaftor (ETI) has led to improvements in pulmonary outcomes, sweat chloride, body mass index (BMI) and quality of life in people with cystic fibrosis (CF). Improved uptake of fat-soluble vitamins and micronutrients has b...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorit Fabricius (Author), Tina Knieling (Author), Noelle Zurmuehl (Author), Leandra Makedon (Author), Joachim Freihorst (Author), Hanna Schmidt (Author), Sebastian Bode (Author)
Format: Book
Published: SpringerOpen, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_65b412cccdaf48c99e9aa37d8d881ccc
042 |a dc 
100 1 0 |a Dorit Fabricius  |e author 
700 1 0 |a Tina Knieling  |e author 
700 1 0 |a Noelle Zurmuehl  |e author 
700 1 0 |a Leandra Makedon  |e author 
700 1 0 |a Joachim Freihorst  |e author 
700 1 0 |a Hanna Schmidt  |e author 
700 1 0 |a Sebastian Bode  |e author 
245 0 0 |a Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight 
260 |b SpringerOpen,   |c 2024-05-01T00:00:00Z. 
500 |a 10.1186/s40348-024-00178-6 
500 |a 2194-7791 
520 |a Abstract Background Highly-effective CFTR-modulator therapy with elexa-/teza-/ivacaftor (ETI) has led to improvements in pulmonary outcomes, sweat chloride, body mass index (BMI) and quality of life in people with cystic fibrosis (CF). Improved uptake of fat-soluble vitamins and micronutrients has been reported for CFTR-modulators but data regarding ETI therapy is lacking. Methods This single-center retrospective study evaluated forced expiratory volume in one second (FEV-1), sweat chloride, BMI, transaminases (AST, ALT), bilirubin, vitamins A, D, E, zinc and selenium in children and adults eligible for ETI. Parameters were assessed before and up to one year after initiation of ETI. Results 58 patients (median age m = 28 years, SD ± 11.6 years, 51.7% female14 < 18 years old) were included. FEV-1 and sweat chloride improved significantly after ETI. There were no changes in BMI or AST. ALT was increased significantly after 4 weeks of ETI but returned to normal levels in further course. Bilirubin levels remained elevated after ETI. Vitamin A was significantly higher 12 months after ETI. No changes were found for vitamins D, E, zinc and selenium. Conclusions This study adds to the evidence that improvements of some fat-soluble vitamin levels can be found after ETI. No changes regarding micronutrients were noted. Individualized follow-up and supplementation are recommended. 
546 |a EN 
690 |a Cystic fibrosis 
690 |a Vitamins 
690 |a Trace elements 
690 |a Micronutrients 
690 |a Highly effective CFTR modulator therapy 
690 |a Individualized therapy 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Molecular and Cellular Pediatrics, Vol 11, Iss 1, Pp 1-11 (2024) 
787 0 |n https://doi.org/10.1186/s40348-024-00178-6 
787 0 |n https://doaj.org/toc/2194-7791 
856 4 1 |u https://doaj.org/article/65b412cccdaf48c99e9aa37d8d881ccc  |z Connect to this object online.